MA54677A - Composés pyrazoles et leur préparation - Google Patents
Composés pyrazoles et leur préparationInfo
- Publication number
- MA54677A MA54677A MA054677A MA54677A MA54677A MA 54677 A MA54677 A MA 54677A MA 054677 A MA054677 A MA 054677A MA 54677 A MA54677 A MA 54677A MA 54677 A MA54677 A MA 54677A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- pyrazole compounds
- pyrazole
- compounds
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/122—Halides of copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201811003859 | 2018-02-01 | ||
| IN201811003855 | 2018-02-01 | ||
| IN201711042921 | 2018-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54677A true MA54677A (fr) | 2021-11-17 |
Family
ID=67478207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054677A MA54677A (fr) | 2018-02-01 | 2019-02-01 | Composés pyrazoles et leur préparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11873289B2 (fr) |
| EP (1) | EP3746434A4 (fr) |
| JP (1) | JP7402804B2 (fr) |
| KR (1) | KR20200118025A (fr) |
| CN (1) | CN111670184A (fr) |
| AU (1) | AU2019213854C1 (fr) |
| BR (1) | BR112020015692A2 (fr) |
| CA (1) | CA3090204A1 (fr) |
| IL (1) | IL276410B2 (fr) |
| MA (1) | MA54677A (fr) |
| MX (1) | MX2020008151A (fr) |
| SG (1) | SG11202007328UA (fr) |
| WO (1) | WO2019150392A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019150392A1 (fr) | 2018-02-01 | 2019-08-08 | Srf Limited | Composés pyrazoles et leur préparation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284386A (ja) * | 2006-04-18 | 2007-11-01 | Kumiai Chem Ind Co Ltd | ３−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤 |
| US8324178B2 (en) * | 2008-10-31 | 2012-12-04 | The Regents Of The University Of California | Method of treatment using alpha-1-adrenergic agonist compounds |
| EP2714680B1 (fr) * | 2011-05-27 | 2015-11-25 | Amira Pharmaceuticals, Inc. | Inhibiteurs de l'autotaxine hétérocycliques et leurs utilisations |
| CN104703972B (zh) | 2012-08-30 | 2017-05-31 | 拜耳农作物科学股份公司 | 3，5‑双(卤烷基)‑吡唑‑4‑甲酸衍生物的脱羧方法 |
| WO2014089913A1 (fr) | 2012-12-12 | 2014-06-19 | 山东亨利医药科技有限责任公司 | Composé bicyclique fonctionnant en tant qu'inhibiteur de tyrosine kinase |
| JP6446464B2 (ja) | 2013-11-01 | 2018-12-26 | エスアールエフ リミテッド | ピラゾール誘導体の製造方法 |
| EP3015458A1 (fr) | 2014-11-03 | 2016-05-04 | Bayer CropScience AG | Procédé de préparation de dérivés de 3,5-bis bis(haloalkyl)pyrazole à partir de a,a-dihaloamines et ketimines |
| KR102585550B1 (ko) | 2015-01-22 | 2023-10-10 | 미요카디아, 인크. | 확장성 심근병증 (dcm)의 치료를 위한 4-메틸술포닐-치환된 피페리딘 우레아 화합물 |
| WO2018132372A1 (fr) | 2017-01-10 | 2018-07-19 | Sanford Burnham Prebys Medical Discovery Institute | Activateurs à petites molécules de nicotinamide phosphoribosyltransférase (nampt) et leurs utilisations |
| AU2018250554A1 (en) | 2017-04-11 | 2019-11-07 | Oric Pharmaceuticals, Inc. | Glucocorticoid receptor modulators |
| WO2019150392A1 (fr) | 2018-02-01 | 2019-08-08 | Srf Limited | Composés pyrazoles et leur préparation |
-
2019
- 2019-02-01 WO PCT/IN2019/050076 patent/WO2019150392A1/fr active Application Filing
- 2019-02-01 KR KR1020207022279A patent/KR20200118025A/ko not_active Application Discontinuation
- 2019-02-01 AU AU2019213854A patent/AU2019213854C1/en active Active
- 2019-02-01 MX MX2020008151A patent/MX2020008151A/es unknown
- 2019-02-01 EP EP19747117.0A patent/EP3746434A4/fr active Pending
- 2019-02-01 BR BR112020015692-2A patent/BR112020015692A2/pt unknown
- 2019-02-01 SG SG11202007328UA patent/SG11202007328UA/en unknown
- 2019-02-01 JP JP2020541983A patent/JP7402804B2/ja active Active
- 2019-02-01 US US16/966,502 patent/US11873289B2/en active Active
- 2019-02-01 CN CN201980011350.9A patent/CN111670184A/zh active Pending
- 2019-02-01 IL IL276410A patent/IL276410B2/en unknown
- 2019-02-01 MA MA054677A patent/MA54677A/fr unknown
- 2019-02-01 CA CA3090204A patent/CA3090204A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210053940A1 (en) | 2021-02-25 |
| SG11202007328UA (en) | 2020-08-28 |
| EP3746434A4 (fr) | 2021-11-17 |
| AU2019213854C1 (en) | 2023-12-14 |
| WO2019150392A1 (fr) | 2019-08-08 |
| IL276410A (en) | 2020-09-30 |
| IL276410B2 (en) | 2024-09-01 |
| CA3090204A1 (fr) | 2019-08-08 |
| JP7402804B2 (ja) | 2023-12-21 |
| BR112020015692A2 (pt) | 2020-12-08 |
| EP3746434A1 (fr) | 2020-12-09 |
| IL276410B1 (en) | 2024-05-01 |
| CN111670184A (zh) | 2020-09-15 |
| JP2021512127A (ja) | 2021-05-13 |
| KR20200118025A (ko) | 2020-10-14 |
| US11873289B2 (en) | 2024-01-16 |
| MX2020008151A (es) | 2020-09-18 |
| AU2019213854A1 (en) | 2020-09-03 |
| AU2019213854B2 (en) | 2023-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50205A (fr) | Formulation de nicotine | |
| MA52489A (fr) | Nouveaux composés | |
| MA55131A (fr) | Nouveaux composés hétérocycliques | |
| MA51530A (fr) | Composés cycliques fondus | |
| MA44225A (fr) | Sulfonylurées et composés apparentés et leur utilisation | |
| MA51200A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies | |
| JP1641786S (ja) | 電子喫煙具 | |
| MA47440A (fr) | Sulfonylurées, composés apparentés, et leur utilisation | |
| MA52948A (fr) | Composés | |
| MA45709A (fr) | Composés diazahétérobicycliques substitués et leur utilisation | |
| GB202307302D0 (en) | Framework for privacy-preserving big-data sharing using distributed ledger | |
| MA51669A (fr) | Composés | |
| MA53003A (fr) | Composés | |
| DK3875085T3 (da) | Edaravon-suspension til oral indgivelse | |
| SG11202100220SA (en) | Pesticidal mixtures comprising indazoles | |
| DK3870578T3 (da) | Terapeutiske forbindelser | |
| DK3847160T3 (da) | Fungicide nitroanilino-substituerede pyrazoler | |
| MA53294A (fr) | Préparation de bactériophages | |
| IL280047A (en) | Formulation of cannabinoid compounds | |
| MA49522A (fr) | Nouveaux composés de quinoléinone | |
| IL284130A (en) | Persistent sprinkler sheath | |
| IL283408A (en) | Pyrazoles as modulators of hemoglobin | |
| MA53430A (fr) | Nouveaux composés | |
| MA52946A (fr) | Composés | |
| JP1648248S (ja) | 電子喫煙具 |